| Current Price | $73.48 | Mkt Cap | $3.5B |
|---|---|---|---|
| Open | $75.10 | P/E Ratio | -17.17 |
| Prev. Close | $73.48 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $73.19 - $75.31 | Volume | 1,201,150 |
| 52-Wk Range | $38.87 - $91.29 | Avg. Daily Vol. | 859,586 |
| Current Price | $73.48 | Mkt Cap | $3.5B |
|---|---|---|---|
| Open | $75.10 | P/E Ratio | -17.17 |
| Prev. Close | $73.48 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $73.19 - $75.31 | Volume | 1,201,150 |
| 52-Wk Range | $38.87 - $91.29 | Avg. Daily Vol. | 859,586 |
The best Bull and Bear pitches based on recency and number of recommendations.
Axsome just acquired a drug for sleep disorders -- and that drug saw triple-digit sales growth last year. And Axsome just won FDA approval for a drug for major depressive disorder. This is expected to become a blockbuster. These are two key growth… More
CNS diseases with patient-reported outcomes are so difficult to show efficacy.
Read the most recent pitches from players about AXSM.
Recs
TMFAdriaCimino
(< 20)
Submitted: 9/13/2022 2:40:57 PM :
Start Price:
$60.23
NASDAQ:AXSM Score:
+14.22
Axsome just acquired a drug for sleep disorders -- and that drug saw triple-digit sales growth last year. And Axsome just won FDA approval for a drug for major depressive disorder. This is expected to become a blockbuster. These are two key growth drivers that are at the beginning of their story.
Recs
TMFjimhalley
(< 20)
Submitted: 5/12/2022 1:07:26 PM :
Start Price:
$24.94
NASDAQ:AXSM Score:
+186.33
The company should benefit from revenue from Sunosi, as well as AXS-05, when that drug is approved.
Recs
folge
(< 20)
Submitted: 5/2/2022 3:54:45 PM :
Start Price:
$34.10
NASDAQ:AXSM Score:
+113.03
They're about to commercialize the world's next blockbuster drug - AXS-05 - and have many others with positive testing results.
Find the members with the highest scoring picks in AXSM.
jeepdrew222 (39.26) Score: +2,695.61
The Score Leader is the player with the highest score across all their picks in AXSM.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| jeepdrew222 | 39.26 | 8/27/2018 |
|
5Y | $2.60 | +2,744.62% | +49.01% | +2,695.61 | 0 Comment | |
|
Under5 | 56.14 |
|
|
5Y | $2.60 | +2,744.62% | +65.04% | +2,679.58 | 0 Comment |
| NextGenStock | < 20 |
|
|
5Y | $3.00 | +2,365.33% | +55.80% | +2,309.54 | 0 Comment | |
| NateVDM214 | < 20 | 6/21/2018 |
|
3Y | $3.15 | +2,247.94% | +55.97% | +2,191.96 | 0 Comment | |
| jumbofaceplate | 21.08 | 5/15/2017 |
|
5Y | $4.10 | +1,703.90% | +79.74% | +1,624.16 | 0 Comment | |
|
|
ababrmon | 36.57 |
|
|
5Y | $5.47 | +1,252.40% | +60.43% | +1,191.97 | 0 Comment |
| warmwind | < 20 | 1/13/2017 |
|
5Y | $5.50 | +1,244.73% | +89.84% | +1,154.89 | 0 Comment | |
| Momentum21 | 37.91 | 6/2/2016 |
|
5Y | $7.68 | +863.02% | +104.72% | +758.30 | 0 Comment | |
| Reallynow222 | 88.92 | 2/28/2019 |
|
5Y | $8.20 | +801.95% | +54.15% | +747.81 | 0 Comment | |
| portefeuille | 98.09 | 1/8/2019 |
|
5Y | $8.11 | +811.96% | +67.60% | +744.36 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
